You are here: Industry Insights > FDA Approval

News List

Alembic’s Doxycycline capsules receives US FDA approval expressbpd
August 01, 2017
The capsules are used in the treatment and prevention of infections caused by bacteria.
GSK Receives FDA Approval for New Self-Injectable Formulation of Benlysta americanpharmaceuticalreview
July 25, 2017
GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody-positive SLE...
Strides Shasun receives US FDA Approval for Cetirizine Softgel Capsules expressbpd
July 25, 2017
First Indian generic company to receive approval for Cetirizine (Softgel)
Janssen Announces FDA Approval of TREMFYA for Severe Plaque Psoriasis americanpharmaceuticalreview
July 18, 2017
Janssen Biotech announced the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of adults living with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Lupin receives FDA approval for generic Flucytosine caps expressbpd
July 11, 2017
Flucytosine capsules is a generic version of Valeant Pharmaceuticals International’s Ancobon Capsules
QIAGEN's QuantiFERON-TB Gold Plus gains U.S. FDA approval biospectrumasia
June 15, 2017
Fourth generation Latent TB blood test combines breakthrough CD4/CD8 design for comprehensive immune response detection with the most flexible blood collection workflow
Pharmadax Receives FDA Approval for Generic Version of Seroquel XR americanpharmaceuticalreview
May 18, 2017
Pharmadax announced the U.S. Food and Drug Administration (FDA) has approved a generic equivalent to Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.
Nearly 1 in 3 drugs found to have safety concerns after FDA approval worldpharmanews
May 11, 2017
How often are safety concerns raised about a drug after it's been approved by the FDA?
FDA Approves ArmonAir RespiClick drugs.com
January 30, 2017
Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma
FDA Approves AirDuo RespiClick drugs.com
January 30, 2017
Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma

Previous page 1 2 3 Next page